BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 10889859)

  • 1. False-positive results in breast cancer screening.
    Evans MF
    Can Fam Physician; 1999 Jan; 45():73-4. PubMed ID: 10889859
    [No Abstract]   [Full Text] [Related]  

  • 2. Population screening for breast cancer by mammography in The Netherlands. Expectations, early results, negative effects and conditions for large-scale screening.
    Hendriks JH; Verbeek AL
    Diagn Imaging Clin Med; 1985; 54(3-4):186-91. PubMed ID: 3896616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening for breast cancer in India--is it an appropriate strategy?
    Moss S
    J Natl Cancer Inst; 2008 Sep; 100(18):1270-1. PubMed ID: 18780862
    [No Abstract]   [Full Text] [Related]  

  • 4. The contribution of clinical breast examination to the accuracy of breast screening.
    Chiarelli AM; Majpruz V; Brown P; Thériault M; Shumak R; Mai V
    J Natl Cancer Inst; 2009 Sep; 101(18):1236-43. PubMed ID: 19720967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cancer screening: medico-legal aspects].
    Buzzi F
    Ann Ig; 2003; 15(1):3-10. PubMed ID: 12666320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk benefit in mass screening programs for breast cancer.
    Miller AB
    Semin Oncol; 1978 Dec; 5(4):351-9. PubMed ID: 104389
    [No Abstract]   [Full Text] [Related]  

  • 7. Screening and prevention of breast cancer in primary care.
    Tice JA; Kerlikowske K
    Prim Care; 2009 Sep; 36(3):533-58. PubMed ID: 19616154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast cancer risk factors and screening: United States, 1987.
    Dawson DA; Thompson GB
    Vital Health Stat 10; 1990 Jan; (172):iii-iv, 1-60. PubMed ID: 2305556
    [No Abstract]   [Full Text] [Related]  

  • 9. The cumulative risk of a false-positive recall in the Norwegian Breast Cancer Screening Program.
    Hofvind S; Thoresen S; Tretli S
    Cancer; 2004 Oct; 101(7):1501-7. PubMed ID: 15378474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Mammography screening: presentation of scientific evidence as a basis for communication with women].
    Mühlhauser I; Höldke B
    Z Arztl Fortbild Qualitatssich; 2000 Oct; 94(9):721-31. PubMed ID: 11127779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for breast cancer. U.S. Preventive Services Task Force, Washington, D.C.
    Am Fam Physician; 1989 Jun; 39(6):89-96. PubMed ID: 2658519
    [No Abstract]   [Full Text] [Related]  

  • 12. [Distressed or relieved? Psychological sequelae of breast cancer screening in Netherlands].
    van Wijngaarden DA
    Ned Tijdschr Geneeskd; 1999 Apr; 143(16):873-4. PubMed ID: 10347659
    [No Abstract]   [Full Text] [Related]  

  • 13. [The efficacy of outpatient examination of the female population for the early diagnosis of breast cancer].
    Demidov VP; Baranov VA; Denisov LE; Zoziuk NT; Gretsova VI
    Vopr Onkol; 1984; 30(8):49-52. PubMed ID: 6485284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are there downsides to mammography screening?
    Baines CJ
    Breast J; 2005; 11 Suppl 1():S7-10. PubMed ID: 15725116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting the risk of a false-positive test for women following a mammography screening programme.
    Njor SH; Olsen AH; Schwartz W; Vejborg I; Lynge E
    J Med Screen; 2007; 14(2):94-7. PubMed ID: 17626709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Control of breast cancer through mass screening.
    Strax P
    Prog Clin Biol Res; 1977; 12():165-76. PubMed ID: 918096
    [No Abstract]   [Full Text] [Related]  

  • 17. Screening for breast cancer.
    Huguley CM
    J Med Assoc Ga; 1987 May; 76(5):310-3. PubMed ID: 3598405
    [No Abstract]   [Full Text] [Related]  

  • 18. Screening for breast cancer in apparently well women.
    Croll J
    Aust Fam Physician; 1985 Apr; 14(4):267, 270-2. PubMed ID: 4015527
    [No Abstract]   [Full Text] [Related]  

  • 19. Magnetic resonance imaging of the breast improves detection of invasive cancer, preinvasive cancer, and premalignant lesions during surveillance of women at high risk for breast cancer.
    Riedl CC; Ponhold L; Flöry D; Weber M; Kroiss R; Wagner T; Fuchsjäger M; Helbich TH
    Clin Cancer Res; 2007 Oct; 13(20):6144-52. PubMed ID: 17947480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Mass screening for breast cancer: remaining questions].
    Verbeek AL
    Ned Tijdschr Geneeskd; 1987 Sep; 131(37):1602-4. PubMed ID: 3670448
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.